Skip to main content
Erschienen in: Die Innere Medizin 8/2019

08.07.2019 | Interstitielle Nephritis | CME

Interstitielle Nephritis

verfasst von: Dr. Anna Laura Herzog, PD Dr. Kai Lopau

Erschienen in: Die Innere Medizin | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die interstitielle Nephritis führt häufig zu einem akuten Nierenversagen und wird oft spät oder nicht erkannt. Hauptursache sind Medikamente. Pathophysiologisch liegt meist eine Typ-IV-Hypersensitivitätsreaktion vor. Zudem gibt es seltenere Formen mit unklarer Ätiologie, die nicht selten unerkannt bleiben. Weil das pathophysiologische Verständnis oft fehlt, stehen kaum Erfolg versprechende Therapien zur Verfügung. Für manche Medikamente ist das Gesamtrisiko zwar gering, wegen häufiger Verordnungen sind die Nebenwirkungen im klinischen Alltag aber durchaus relevant. Zudem führen neue Ansätze wie die Immuntherapien zu Nebeneffekten, die nicht in vollem Umfang abzusehen sind. Bei vielen Erkrankungen erhöht das Auftreten eines akuten Nierenversagens die Mortalität und Morbidität. Eine potenziell irreversible chronische Niereninsuffizienz bewirkt weitere Komorbiditäten und schränkt die Lebensqualität ein. Die Therapie ist schwierig und meist empirisch.
Literatur
1.
Zurück zum Zitat Praga M, Sevillano A, Auñón P, González E (2015) Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant 30:1472–1479CrossRef Praga M, Sevillano A, Auñón P, González E (2015) Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant 30:1472–1479CrossRef
2.
Zurück zum Zitat Goicoechea M, Rivera F, López-Gómez JM (2013) Spanish registry of glomerulonephritis. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 28:112–115CrossRef Goicoechea M, Rivera F, López-Gómez JM (2013) Spanish registry of glomerulonephritis. Increased prevalence of acute tubulointerstitial nephritis. Nephrol Dial Transplant 28:112–115CrossRef
3.
Zurück zum Zitat Tonelli M, Wiebe N, Manns BJ et al (2018) Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA 1:e184852 Tonelli M, Wiebe N, Manns BJ et al (2018) Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA 1:e184852
4.
Zurück zum Zitat Praga M, González E (2010) Acute interstitial nephritis. Kidney Int 77:956–961CrossRef Praga M, González E (2010) Acute interstitial nephritis. Kidney Int 77:956–961CrossRef
5.
Zurück zum Zitat Rodríguez-Poncelas A, Barceló MA, Saez M, Coll-de-Tuero G (2018) Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort. PLoS ONE 13:e204231CrossRef Rodríguez-Poncelas A, Barceló MA, Saez M, Coll-de-Tuero G (2018) Duration and dosing of Proton Pump Inhibitors associated with high incidence of chronic kidney disease in population-based cohort. PLoS ONE 13:e204231CrossRef
6.
Zurück zum Zitat Krishnan N, Perazella MA (2015) Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis 9:3–13PubMed Krishnan N, Perazella MA (2015) Drug-induced acute interstitial nephritis: pathology, pathogenesis, and treatment. Iran J Kidney Dis 9:3–13PubMed
7.
Zurück zum Zitat Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6:461–470CrossRef Perazella MA, Markowitz GS (2010) Drug-induced acute interstitial nephritis. Nat Rev Nephrol 6:461–470CrossRef
8.
Zurück zum Zitat Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB (1974) Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med 291:381–384CrossRef Border WA, Lehman DH, Egan JD, Sass HJ, Glode JE, Wilson CB (1974) Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med 291:381–384CrossRef
9.
Zurück zum Zitat Palevsky PM, Liu KD, Brophy PD et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61:649–672CrossRef Palevsky PM, Liu KD, Brophy PD et al (2013) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 61:649–672CrossRef
10.
Zurück zum Zitat Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8–11CrossRef Baker RJ, Pusey CD (2004) The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19:8–11CrossRef
11.
Zurück zum Zitat Farid S, Mahmood M, Saleh AOM et al (2018) Clinical manifestations and outcomes of fluoroquinolone-related acute interstitial nephritis. Mayo Clin Proc 93:25–31CrossRef Farid S, Mahmood M, Saleh AOM et al (2018) Clinical manifestations and outcomes of fluoroquinolone-related acute interstitial nephritis. Mayo Clin Proc 93:25–31CrossRef
12.
Zurück zum Zitat Xie H, Chen H, Hu Y et al (2013) Clindamycin-induced acute kidney injury: large biopsy case series. Am J Nephrol 38:179–183CrossRef Xie H, Chen H, Hu Y et al (2013) Clindamycin-induced acute kidney injury: large biopsy case series. Am J Nephrol 38:179–183CrossRef
14.
Zurück zum Zitat Perazella MA, Bomback AS (2013) Urinary eosinophils in AIN: farewell to an old biomarker? Clin J Am Soc Nephrol 8:1841–1843CrossRef Perazella MA, Bomback AS (2013) Urinary eosinophils in AIN: farewell to an old biomarker? Clin J Am Soc Nephrol 8:1841–1843CrossRef
15.
Zurück zum Zitat Raghavan R, Eknoyan G (2014) Acute interstitial nephritis—a reappraisal and update. Clin Nephrol. 82(3):149–162CrossRef Raghavan R, Eknoyan G (2014) Acute interstitial nephritis—a reappraisal and update. Clin Nephrol. 82(3):149–162CrossRef
16.
Zurück zum Zitat Blank M‑L, Parkin L, Paul C, Herbison P (2014) A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int 86:837–844CrossRef Blank M‑L, Parkin L, Paul C, Herbison P (2014) A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int 86:837–844CrossRef
17.
Zurück zum Zitat Ramachandran R, Kumar K, Nada R, Jha V, Gupta KL, Kohli HS (2015) Drug-induced acute interstitial nephritis: a clinicopathological study and comparative trial of steroid regimens. Indian J Nephrol 25:281CrossRef Ramachandran R, Kumar K, Nada R, Jha V, Gupta KL, Kohli HS (2015) Drug-induced acute interstitial nephritis: a clinicopathological study and comparative trial of steroid regimens. Indian J Nephrol 25:281CrossRef
19.
Zurück zum Zitat De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M (2014) Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997–2009. J Pediatr Gastroenterol Nutr 58:220–225CrossRef De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M (2014) Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997–2009. J Pediatr Gastroenterol Nutr 58:220–225CrossRef
20.
Zurück zum Zitat Lazarus B, Chen Y, Wilson FP et al (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238CrossRef Lazarus B, Chen Y, Wilson FP et al (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238CrossRef
21.
Zurück zum Zitat Björnsson E, Abrahamsson H, Simrén M et al (2006) Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 24:945–954CrossRef Björnsson E, Abrahamsson H, Simrén M et al (2006) Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial. Aliment Pharmacol Ther 24:945–954CrossRef
22.
Zurück zum Zitat Cipriani A, Hawton K, Stockton S, Geddes JR (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 346:f3646CrossRef Cipriani A, Hawton K, Stockton S, Geddes JR (2013) Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 346:f3646CrossRef
23.
Zurück zum Zitat Bendz H, Schön S, Attman P‑O, Aurell M (2010) Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77:219–224CrossRef Bendz H, Schön S, Attman P‑O, Aurell M (2010) Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77:219–224CrossRef
24.
Zurück zum Zitat Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D’Agati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439–1448PubMed Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D’Agati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439–1448PubMed
25.
Zurück zum Zitat Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734–1736CrossRef Leach DR, Krummel MF, Allison JP (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271:1734–1736CrossRef
26.
Zurück zum Zitat Wanchoo R, Karam S, Uppal NN et al (2017) Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol 45:160–169CrossRef Wanchoo R, Karam S, Uppal NN et al (2017) Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol 45:160–169CrossRef
27.
Zurück zum Zitat Belliere J, Meyer N, Mazieres J et al (2016) Acute interstitial nephritis related to immune checkpoint inhibitors. Br J Cancer 115:1457–1461CrossRef Belliere J, Meyer N, Mazieres J et al (2016) Acute interstitial nephritis related to immune checkpoint inhibitors. Br J Cancer 115:1457–1461CrossRef
28.
Zurück zum Zitat Schneeberger C, Holleman F, Geerlings SE (2016) Febrile urinary tract infections: pyelonephritis and urosepsis. Curr Opin Infect Dis 29:80–85CrossRef Schneeberger C, Holleman F, Geerlings SE (2016) Febrile urinary tract infections: pyelonephritis and urosepsis. Curr Opin Infect Dis 29:80–85CrossRef
29.
Zurück zum Zitat Artero A, Inglada L, Gómez-Belda A et al (2018) The clinical impact of bacteremia on outcomes in elderly patients with pyelonephritis or urinary sepsis: a prospective multicenter study. PLoS ONE 13:e191066CrossRef Artero A, Inglada L, Gómez-Belda A et al (2018) The clinical impact of bacteremia on outcomes in elderly patients with pyelonephritis or urinary sepsis: a prospective multicenter study. PLoS ONE 13:e191066CrossRef
30.
Zurück zum Zitat Chung VY, Tai CK, Fan CW, Tang CN (2014) Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality. Hong Kong Med J 20:285–289PubMed Chung VY, Tai CK, Fan CW, Tang CN (2014) Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality. Hong Kong Med J 20:285–289PubMed
31.
Zurück zum Zitat Fölsch UR, Kochsiek K, Schmidt RF (2013) Pathophysiologie. Springer, Berlin Heidelberg Fölsch UR, Kochsiek K, Schmidt RF (2013) Pathophysiologie. Springer, Berlin Heidelberg
33.
Zurück zum Zitat Li L, Parwani AV (2011) Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135:4 Li L, Parwani AV (2011) Xanthogranulomatous pyelonephritis. Arch Pathol Lab Med 135:4
34.
Zurück zum Zitat Sangüesa Nebot C, Picó Aliaga S, Serrano Durbá A, Roca MJ (2018) Xantogranulomatous pyeloneprhritis in children. Insights Imaging 9:643–651CrossRef Sangüesa Nebot C, Picó Aliaga S, Serrano Durbá A, Roca MJ (2018) Xantogranulomatous pyeloneprhritis in children. Insights Imaging 9:643–651CrossRef
35.
Zurück zum Zitat Jurke A, Bannert N, Brehm K et al (2015) Serological survey of Bartonella spp., Borrelia burgdorferi, Brucella spp., Coxiella burnetii, Francisella tularensis, Leptospira spp., Echinococcus, Hanta‑, TBE- and XMR-virus infection in employees of two forestry enterprises in North Rhine-Westphalia, Germany, 2011–2013. Zentralbl Bakteriol 305:652–662 Jurke A, Bannert N, Brehm K et al (2015) Serological survey of Bartonella spp., Borrelia burgdorferi, Brucella spp., Coxiella burnetii, Francisella tularensis, Leptospira spp., Echinococcus, Hanta‑, TBE- and XMR-virus infection in employees of two forestry enterprises in North Rhine-Westphalia, Germany, 2011–2013. Zentralbl Bakteriol 305:652–662
36.
Zurück zum Zitat Latus J, Schwab M, Tacconelli E et al (2015) Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant 30:245–251CrossRef Latus J, Schwab M, Tacconelli E et al (2015) Acute kidney injury and tools for risk-stratification in 456 patients with hantavirus-induced nephropathia epidemica. Nephrol Dial Transplant 30:245–251CrossRef
37.
Zurück zum Zitat Olsson GE, Leirs H, Henttonen H (2010) Hantaviruses and their hosts in europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis 10:549–561CrossRef Olsson GE, Leirs H, Henttonen H (2010) Hantaviruses and their hosts in europe: reservoirs here and there, but not everywhere? Vector Borne Zoonotic Dis 10:549–561CrossRef
38.
Zurück zum Zitat Mackensen F, Smith JR, Rosenbaum JT (2007) Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 114:995–999CrossRef Mackensen F, Smith JR, Rosenbaum JT (2007) Enhanced recognition, treatment, and prognosis of tubulointerstitial nephritis and uveitis syndrome. Ophthalmology 114:995–999CrossRef
40.
Zurück zum Zitat Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195–208CrossRef Mandeville JT, Levinson RD, Holland GN (2001) The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46:195–208CrossRef
41.
Zurück zum Zitat Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL (1994) Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24:172–180CrossRef Depierreux M, Van Damme B, Vanden Houte K, Vanherweghem JL (1994) Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis 24:172–180CrossRef
42.
Zurück zum Zitat Surendra M, Raju S, Chandragiri S, Uppin MS, Raju N (2019) Steroid therapy in drug induced acute interstitial nephritis- Retrospective analysis of 83 cases. Saudi J Kidney Dis Transplant 30:157–165CrossRef Surendra M, Raju S, Chandragiri S, Uppin MS, Raju N (2019) Steroid therapy in drug induced acute interstitial nephritis- Retrospective analysis of 83 cases. Saudi J Kidney Dis Transplant 30:157–165CrossRef
43.
Zurück zum Zitat Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24:253–263CrossRef Andreoli SP (2009) Acute kidney injury in children. Pediatr Nephrol 24:253–263CrossRef
44.
Zurück zum Zitat Muriithi AK, Leung N, Valeri AM et al (2014) Biopsy-proven acute interstitial nephritis, 1993–2011: a case series. Am J Kidney Dis 64:558–566CrossRef Muriithi AK, Leung N, Valeri AM et al (2014) Biopsy-proven acute interstitial nephritis, 1993–2011: a case series. Am J Kidney Dis 64:558–566CrossRef
45.
Zurück zum Zitat González E, Gutiérrez E, Galeano C et al (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946CrossRef González E, Gutiérrez E, Galeano C et al (2008) Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73:940–946CrossRef
46.
Zurück zum Zitat Jahnukainen T, Saarela V, Arikoski P et al (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253–1260CrossRef Jahnukainen T, Saarela V, Arikoski P et al (2013) Prednisone in the treatment of tubulointerstitial nephritis in children. Pediatr Nephrol 28:1253–1260CrossRef
47.
Zurück zum Zitat Gutiérrez E, Egido J, Rubio-Navarro A et al (2012) Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 121:c42–c53CrossRef Gutiérrez E, Egido J, Rubio-Navarro A et al (2012) Oxidative stress, macrophage infiltration and CD163 expression are determinants of long-term renal outcome in macrohematuria-induced acute kidney injury of IgA nephropathy. Nephron Clin Pract 121:c42–c53CrossRef
48.
Zurück zum Zitat Shao T, Weinstein J, Jothy S, Goldstein M (2016) Severe acute interstitial nephritis: response to therapy with antithymocyte globulin. Kidney Int Rep 2:138–141CrossRef Shao T, Weinstein J, Jothy S, Goldstein M (2016) Severe acute interstitial nephritis: response to therapy with antithymocyte globulin. Kidney Int Rep 2:138–141CrossRef
Metadaten
Titel
Interstitielle Nephritis
verfasst von
Dr. Anna Laura Herzog
PD Dr. Kai Lopau
Publikationsdatum
08.07.2019
Verlag
Springer Medizin
Erschienen in
Die Innere Medizin / Ausgabe 8/2019
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-019-0634-3

Weitere Artikel der Ausgabe 8/2019

Die Innere Medizin 8/2019 Zur Ausgabe

Schwerpunkt: Dermatologie und Innere Medizin

Hautveränderungen bei Vaskulitiden

Schwerpunkt: Dermatologie und Innere Medizin

Hautveränderungen helfen bei der Einordnung von Vaskulitiden

Kongresse des BDI

Kongresse des BDI

Mitteilungen des BDI

Mitteilungen des BDI

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.